The Community Oncology Alliance (COA) maintains a Corporate Member Program for qualified industry companies including biotechnology, pharmaceutical, genomic, drug delivery and distribution, and other entities. This is consistent with COA’s mission of uniting the cancer community in order to enhance the quality of cancer care. The purpose of the Corporate Member Program is to:
- Foster enhanced communications between community oncology and corporate members to improve the cancer care delivery system
- Provide a forum for addressing common issues (not specific brands/products or product-specific issues) that impact patient care delivery
COA maintains a strict policy of independence from commercial influences, such as those related to specific companies, products, or services. The COA Board of Directors enforces this policy. Fundamentally, a mission of fostering and protecting the quality, affordability, and accessibility of cancer care for all Americans governs every COA policy and endeavor. Funds are used for education, projects, advocacy, staffing, and to maintain an office in Washington, D.C.